Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 13Dermatologic 2CNS 2Breast 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1Endocrine 1

Conditions

Multiple Myeloma 7Lymphoma, Non-Hodgkin 2Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Hematologic Neoplasms 1Glioblastoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Specimen Handling 4Zoledronic Acid 3Vorinostat 3Azacitidine 3venetoclax 2trametinib 2ruxolitinib 2pertuzumab 2palbociclib 2dabrafenib 2copanlisib 2abiraterone 2Sunitinib 2Sorafenib 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Immunoglobulin G 2HhAntag691 2Fluorouracil 2Doxorubicin 2Disulfides 2Dasatinib 2Clodronic Acid 2Bevacizumab 2Afatinib 2Ado-Trastuzumab Emtansine 22C4 antibody 2ulixertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × temsirolimus × Plasma cell × Clear all
NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

M.D. Anderson Cancer Center

Phase 1 Completed
180 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡